Description
Bravylol contains nebivolol, a selective β1-blocker, which reduces heart rate, blood pressure and peripheral systemic vascular resistance.
Indications
Bravylol is indicated for the treatment of:
– essential hypertension;
– stable mild and moderate chronic heart failure in addition to standard therapies in elderly patients (>70 years).
Subject to medical prescription.
Concentration and pharmaceutical form: 5 mg tablets
